Biomolecules & Therapeutics 2024; 32(2): 261-261
Erratum to "Tanshinone IIA Protects Endothelial Cells from H2O2-Induced Injuries via PXR Activation" [Biomol Ther 25(6), 599-608 (2017)]
Haiyan Zhu1,2, Zhiwu Chen1, Zengchun Ma2, Hongling Tan2, Chengrong Xiao2, Xianglin Tang2, Boli Zhang3, Yuguang Wang1,2,* and Yue Gao1,2,*
1Department of Pharmacology, Anhui Medical University, Hefei 230032,
2Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850,
3Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
*E-mail: (Wang YG), (Gao Y)
Tel: +86-10-68210077-932201 (Wang YG), +86-10-68210077-931312 (Gao Y)
Fax: +86-10-6821-4653 (Wang YG), +86-10-6821-4653 (Gao Y)
Published online: March 1, 2024.
© The Korean Society of Applied Pharmacology. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upon reviewing our published work, we realized that the representative images of the Rifampicin (RIF) group in Fig. 6A were found to be misplaced due to mishandling in the manuscript preparation.

To rectify this error, we have prepared the correct versions of these figures shown below.

Figure 6. (A) Tan IIA inhibits H2O2-induced inflammation via PXR activation.

This Article

Cited By Articles
  • CrossRef (0)

Social Network Service